{
    "2021-06-02": [
        [
            {
                "time": "2021-06-02",
                "original_text": "富时罗素季度调整结果公布，速看新增剔除A股标的全名单",
                "features": {
                    "keywords": [
                        "富时罗素",
                        "季度调整",
                        "新增",
                        "剔除",
                        "A股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-18",
                "original_text": "富时中国A50新纳入、剔除各2只A股，6月18日收盘后生效",
                "features": {
                    "keywords": [
                        "富时中国A50",
                        "纳入",
                        "剔除",
                        "金龙鱼",
                        "智飞生物",
                        "恒力石化",
                        "中公教育"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-02",
                "original_text": "A股资金流向（6月2日）：资金大幅出逃，医药板块成“重灾区”",
                "features": {
                    "keywords": [
                        "A股",
                        "资金流向",
                        "医药板块",
                        "重灾区"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-02",
                "original_text": "新冠检测及疫苗板块回调，热景生物跌超13%",
                "features": {
                    "keywords": [
                        "新冠检测",
                        "疫苗",
                        "回调",
                        "热景生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-02",
                "original_text": "医药行业周报：建议持续关注创新药等高景气领域相关优质企业",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "创新药",
                        "高景气领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-02",
                "original_text": "中泰证券：新冠疫苗接种加速推进，商业化价值有望从二季度开始兑现",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "新冠疫苗",
                        "接种",
                        "商业化价值",
                        "二季度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}